MedPath

Chlorothiazide Sodium

Chlorothiazide Sodium for Injection, USP

Approved
Approval ID

5046a4d7-7742-4f19-930a-2582cb41474e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Aug 29, 2022

Manufacturers
FDA

Akorn

DUNS: 117693100

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Chlorothiazide Sodium

PRODUCT DETAILS

NDC Product Code17478-419
Application NumberNDA011145
Marketing CategoryC73605
Route of AdministrationINTRAVENOUS
Effective DateAugust 10, 2012
Generic NameChlorothiazide Sodium

INGREDIENTS (3)

Sodium HydroxideInactive
Code: 55X04QC32I
Classification: IACT
MannitolInactive
Quantity: 250 mg in 1 1
Code: 3OWL53L36A
Classification: IACT
Chlorothiazide SodiumActive
Quantity: 500 mg in 1 1
Code: SN86FG7N2K
Classification: ACTIM

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Chlorothiazide Sodium - FDA Drug Approval Details